Home
Conditions
Lipid Metabolism, Inborn Errors

Clinical trial condition

Lipid Metabolism, Inborn Errors

Explore clinical trials studying Lipid Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

834 public trials 155 recruiting studies

Refine in advanced search Browse all conditions

Lipid Metabolism, Inborn Errors trial results

Completed

Phase 2 Study of Obeticholic Acid for Lipodystrophy Patients

NCT02430077

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Familial Partial Lipodystrophy, +13 more
Locations: UT Southwestern Medical Center 5323 Harry Hines Blvd Dallas, Texas, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Completed

The Use of Mobile Health Technology and Behavioral Economics to Encourage Adherence in Adolescents

NCT04458766

Conditions: Adherence, Medication, Behavior, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
Locations: Boston Children's Hospital Boston, Massachusetts, United States

View Trial Details

Completed

A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED)

NCT00093899

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +11 more
Locations: Not specified

View Trial Details

Completed

Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)

NCT00552097

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +14 more
Locations: Not specified

View Trial Details

Completed

Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)

NCT00092573

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Not specified

View Trial Details

Completed

Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)

NCT00092560

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease

NCT03425539

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
Locations: University of Alabama at Birmingham - Nephrology Research Clinic Birmingham, Alabama, United States

University of California Irvine Irvine, California, United States

UCSF Benioff Children's Hospital Oakland Oakland, California, United States

University of Florida College of Medicine - Division of Nephrology, Hypertension & Renal Transplantation Gainesville, Florida, United States

View all 49 locations

View Trial Details

Completed

A Study to Compare the Relative Bioavailability of Two Iberdomide (CC-220) Formulations and to Assess The Effect Of Food on the Drug Levels of Iberdomide in Healthy Adult Participants

NCT05899738

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Local Institution - 0001 Daytona Beach, Florida, United States

View Trial Details

Completed

Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia

NCT04233918

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations: Regeneron Research Site Wilmington, Delaware, United States

Regeneron Research Site Boca Raton, Florida, United States

Regeneron Research Site Kansas City, Kansas, United States

Regeneron Research Center Boston, Massachusetts, United States

View Trial Details

Completed

A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency

NCT02004704

Conditions: Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
Locations: Investigational Site Number 840001 New York, United States

Investigational Site Number 056001 Leuven, Belgium

Investigational Site Number 076001 Porto Alegre, Brazil

Investigational Site Number 250002 Bron, France

View Trial Details

Lipid Metabolism, Inborn Errors

Lipid Metabolism, Inborn Errors trial results

Related conditions